HM
HUTCHMED (China) Limited
HMDCF · OTC
$2.16 +0.00% (+$0.00)
Market Cap $1.88B
P/E Ratio 104.97x
Div. Yield -
ROE 1.43%
Bulios Fair Price
$1.9
12.0% downside
Current Price
$2.16
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HMDCF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
7/9Valuation
33 /100
Expensive P/S 3.42x
P/B 1.49x
P/FCF 188.68x
Growth
70 /100
Growing Book val. growth 26.58%
Rev. growth 8.81%
FCF growth N/A
Profitability
11 /100
Weak Net margin 3.26%
Op. margin 6.33%
FCF margin 1.81%
Quality
7 /100
Poor ROE 1.43%
ROA 1.03%
Asset turnover 0.32x
Debt
100 /100
Low Current ratio 5.64x
Debt/Equity 0.07x
Net debt/EBITDA N/A
Stability
22 /100
Unstable Rev. volatility 66.86%
EPS volatility 626.17%
Profitable years 3
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HMDCF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Chig Fung Cheng
Employees
1,796
Headquarters
Hong Kong
Upcoming events
04 MAR
Earnings
Upcoming earnings report